Arvinas (ARVN) EBIT Margin (2017 - 2026)
Arvinas (ARVN) posted quarterly EBIT Margin of 408.97% for Q1 2026, down 44679.0% year-over-year from N/an in Q1 2025, and up 47.92% quarter-over-quarter from 785.26% in Q4 2025.
Powered by 
Analysis
Arvinas (ARVN) EBIT Margin (2017 - 2026) Analysis & Trends
Arvinas' EBIT Margin history runs 10 years deep, the most recent figure standing at 408.97% for Q1 2026.
- In Q1 2026, EBIT Margin fell 44679.0% year-over-year to 408.97%; the TTM figure through Mar 2026 stood at 283.78% (down 26139.0% YoY), while the FY2025 annual figure was 45.13%, up 4986.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 408.97%, up from 785.26% in the prior quarter.
- The five-year high for EBIT Margin was 383.53% in Q4 2023, with the low at 785.26% in Q4 2025.
- The 5-year median for EBIT Margin is 194.67% (2022), against an average of 186.64%.
- The sharpest annual moves came in 2022 and 2025: EBIT Margin soared 74896 bps in 2022, then plunged 68695 bps in 2025.
- Arvinas' EBIT Margin stood at 200.0% in 2022, then soared by 292 bps to 383.53% in 2023, then sank by 126 bps to 98.31% in 2024, then plunged by 699 bps to 785.26% in 2025, then surged by 48 bps to 408.97% in 2026.
- Business Quant data shows ARVN's EBIT Margin at 408.97% in Q1 2026, 785.26% in Q4 2025, and 104.53% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -562.07% |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 19.06% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 17.93% |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 19.75% |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 10 | Arvinas | 608.15 Mn | 40.25 Mn | - | 65.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.72% |
| Mar 31, 2026 | -408.97% |
| Dec 31, 2025 | -785.26% |
| Sep 30, 2025 | -104.53% |
| Jun 30, 2025 | -319.20% |
| Mar 31, 2025 | 37.82% |
| Dec 31, 2024 | -98.31% |
| Sep 30, 2024 | -58.89% |
| Jun 30, 2024 | -63.40% |
| Mar 31, 2024 | -329.25% |
| Dec 31, 2023 | 383.53% |
| Sep 30, 2023 | -213.58% |
| Jun 30, 2023 | -136.88% |
| Mar 31, 2023 | -269.85% |
| Dec 31, 2022 | -200.00% |
| Sep 30, 2022 | -193.67% |
| Jun 30, 2022 | -194.67% |
| Mar 31, 2022 | -217.74% |
| Dec 31, 2021 | -143.07% |
| Sep 30, 2021 | -508.60% |